The parathyroid hormone-related protein (PTHrP) gene: Use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis

We analyzed the use of different promoters and the splicing patterns of the exons encoding 5'- and 3'-untranslated sequence amounts of parathyroid hor mone-related protein (PTHrP) gene products in breast cancers. Tumor samples from 74 cases of primary breast cancer that had been followed from 1 to 14 years were selected retrospectively according to the occurrence of metasta sis: 18 patients developed no metastasis (NM), 56 developed metastases (M), 22 of whom developed metastases in soft tissues (MB-) and 34 of whom; deve loped bone metastases (MB+). The amount of the 1-139 isoform mRNA was much higher in the tumors of patients who later developed metastases (M: 0.29 +/ - 0.03) than in those of patients who developed no metastases (NM, 0.13 +/- 0.03; p < 0.01). This isoform mRNA was also more abundant in breast tumors from patients who developed bone metastases (MB+, 0.39 +/- 0.04) than in t hose of patients who developed metastases in soft tissues (MB-, 0.15 +/- 0. 03; p < 0.0001). By contrast, the amounts of the 1-141 isoform mRNA in thes e three groups of tumors were similar, but its concentration was higher in the tumors of premenopausal women than in those of postmenopausal women (p < 0.05). Analysis with 5' untranslated regions-specific primers showed tran scription from all three putative transcription start sites of PTHrP (P1, P 2, and P3). The P3-initiated transcripts were more abundant in patients who developed metastases (M, 0.31 +/- 0.03) than in the nommetastatic tumors ( NM, 0.13 +/- 0.03; p < 0.01). The amount of P3 element did not differ with the site of metastasis (BM+, 0.32 +/- 0.05; BM-, 0.28 +/- 0.05; NS), The sa me trend was observed for the P2 element. However, the use of PZ-initiated messages was strongly associated with the absence of estrogen receptors fro m the breast tumors (p < 0.01). We thus find a close association between th e pattern of PTHrP gene expression and the outcome of breast cancer. The P3 -initiated start site and the presence of PTHrP 139 mRNA could help identif y patients at risk of developing metastases.